Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | EXEL | RGEN | HALO | ||
Company | Exelixis Inc | Repligen Corp | Halozyme Therapeutic | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 21.96 | 120.86 | 52.05 | ||
High | 22.17 | 121.81 | 52.50 | ||
Low | 21.87 | 119.76 | 51.36 | ||
Last | 22.10 | 120.08 | 51.56 | ||
Change | +0.14 | -0.69 | -0.45 | ||
% Change | +0.64% | -0.57% | -0.87% | ||
Volume | 630,300 | 577,500 | 742,100 | ||
20-Day Average Volume | 1,592,900 | 942,260 | 1,595,070 | ||
Previous Close | 21.96 | 120.77 | 52.01 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 22.08 | 128.70 | 51.09 | ||
20-Day Raw Stochastic | 54.01% | 16.24% | 71.82% | ||
20-Day Relative Strength | 51.48% | 29.84% | 63.84% | ||
Weighted Alpha | +10.31 | -31.42 | +49.97 | ||
Today's Opinion | 8% Buy | 88% Sell | 100% Buy | ||
Previous Opinion | 24% Sell | 88% Sell | 100% Buy | ||
Last Month's Opinion | 16% Sell | 88% Sell | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -1.91% since 06/27/24 | -5.14% since 06/27/24 | -0.14% since 06/27/24 | ||
Low | 21.82 on 07/03/24 | 119.76 on 07/05/24 | 50.68 on 07/02/24 | ||
High | 22.73 on 07/01/24 | 128.46 on 06/28/24 | 53.22 on 07/01/24 | ||
1-Month | |||||
%Chg | +0.64% since 06/05/24 | -20.32% since 06/05/24 | +12.95% since 06/05/24 | ||
Low | 21.36 on 06/20/24 | 113.50 on 06/20/24 | 47.33 on 06/06/24 | ||
High | 22.73 on 07/01/24 | 154.02 on 06/06/24 | 53.22 on 07/01/24 | ||
3-Month | |||||
%Chg | -4.49% since 04/05/24 | -30.91% since 04/05/24 | +25.54% since 04/05/24 | ||
Low | 20.14 on 05/29/24 | 113.50 on 06/20/24 | 37.73 on 04/19/24 | ||
High | 23.89 on 04/29/24 | 182.21 on 04/09/24 | 53.22 on 07/01/24 | ||
6-Month | |||||
%Chg | -4.91% since 01/05/24 | -30.04% since 01/05/24 | +46.81% since 01/05/24 | ||
Low | 19.20 on 01/08/24 | 113.50 on 06/20/24 | 33.15 on 02/05/24 | ||
High | 24.07 on 03/21/24 | 211.13 on 02/16/24 | 53.22 on 07/01/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 6,658,272 | 6,748,143 | 6,619,521 | ||
Shares Outstanding, K | 303,200 | 55,876 | 127,274 | ||
Annual Sales | 1,830,210,000 | 638,760,000 | 829,250,000 | ||
Annual Net Income | 207,770,000 | 41,580,000 | 281,590,000 | ||
Last Quarter Sales | 425,230,000 | 151,350,000 | 195,880,000 | ||
Last Quarter Net Income | 37,320,000 | 2,090,000 | 76,820,000 | ||
60-Month Beta | 0.54 | 0.95 | 1.27 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.17 on 04/30/24 | 0.28 on 05/01/24 | 0.79 on 05/07/24 | ||
Latest Earnings Date | 08/06/24 | 08/07/24 | 08/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 34.61 | 87.69 | 18.13 |